SCHEMBL24326682

SCHEMBL24326682

CCOC(=O)CN(CC(=O)CNC(=O)OC(C)(C)C)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.51
CTSS P25774 3/20 0.47
CTSL P07711 2/20 0.47
CTSB P07858 2/20 0.47
PPID Q08752 1/20 0.46
ALDH1A1 P00352 4/20 0.44
SYK P43405 1/20 0.44
IDO1 P14902 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA7 P43166 1/20 0.39
CA14 Q9ULX7 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9236772 0.86 AKT1 (0.51) AKT1CTSSCTSLCTSBPPID
SCHEMBL7745572 0.85 CTSL (0.53) AKT1CTSSCTSLCTSBPPID
SCHEMBL24326683 0.83 SYK (0.48) AKT1CTSSCTSLCTSBPPID
SCHEMBL27132402 0.80 AKT1 (0.49) AKT1CTSSCTSLCTSBSYK
SCHEMBL24326681 0.80 AKT1 (0.49) AKT1CTSSCTSLCTSBSYK
SCHEMBL3184733 0.80 ALDH1A1 (0.54) PPIDALDH1A1SMN1; SMN2LMNAPOLB
SCHEMBL26869291 0.79 SYK (0.52) AKT1CTSSCTSLCTSBSYK
SCHEMBL254781 0.78 ALDH1A1 (0.53) PPIDALDH1A1SMN1; SMN2LMNAPOLB
SCHEMBL24326687 0.78 AKT1 (0.47) AKT1CTSSCTSLCTSBSYK
SCHEMBL34474141 0.78 AKT1 (0.47) AKT1CTSSCTSLCTSBPPID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed